Chapter 19.04
COMMERCIAL CANNABIS TESTING, MANUFACTURING, AND RESEARCH AND DEVELOPMENT OPERATING STANDARDS

Sections:

19.04.010    Commercial cannabis testing, manufacturing, and research and development operating standards.

19.04.010 Commercial cannabis testing, manufacturing, and research and development operating standards.

A. It is hereby declared to be unlawful and a public nuisance for any person or persons owning, in whole or in part, leasing, occupying, or having charge or possession of any legal parcel or premises within any zoning district in the city of Seaside to test, manufacture cannabis products, or to engage in research and development of cannabis except as provided for in this chapter.

B. No cannabis or cannabis products at the premises or location where any action governed by this chapter takes place shall be visible to anyone outside the facility on public or other private property, nor shall medical cannabis or any product containing medical cannabis be visible from the exterior of any premises.

C. No medical or adult marijuana shall be dispensed from a testing, manufacturing or research and development site and such sites shall not be open to the public. Security measures sufficient to restrict access to only those admitted to the site and to deter trespass and theft of medical or adult cannabis or medical or adult cannabis products shall be provided and maintained. If on-site security is utilized, security shall be licensed and possess a valid Department of Consumer Affairs “Security Guard Card” at all times.

D. Hazardous materials shall be properly labeled and stored to avoid contamination through erosion, leakage, or inadvertent damage from rodents, pests, or wildlife.

E. A minor use permit for testing, manufacturing and research and development of cannabis and cannabis products shall not be granted by the city unless all of the following findings are made based on substantial evidence:

1. The activity, as proposed, will comply with all of the requirements of the state and city, and any additional conditions of license for the testing, manufacturing, or research and development of cannabis or cannabis products, including approval of a cannabis development/operating agreement by and between the city and owner.

2. The use, as approved and conditioned, will not result in significant unavoidable impacts on the environment.

3. The use includes adequate measures that minimize use of water at the site.

4. Any cultivation includes adequate quality control measures to ensure cannabis cultivated at the site meets industry standards.

5. The use shall include adequate measures that address the federal enforcement priorities for cannabis activities including restricting access to minors, and ensuring that cannabis and cannabis products are not supplied to unlicensed and unpermitted persons within the state and not distributed out of state.

6. The applicant, owner, and permittees agree to submit to, and pay for, inspections of the operations and relevant records or documents necessary to determine compliance with this chapter from any enforcement officer of the city of Seaside or their designee.

7. Any person testing, manufacturing or performing research and development operations using cannabis shall obtain a valid and fully executed commercial cannabis development/operating agreement prior to commencing operations and must maintain such agreement in good standing in order to continue operations.

8. The owner shall be responsible for ensuring that all commercial cannabis activities at the site operate in good standing with all permits and licenses required by state law. Failure to take appropriate action to evict or otherwise remove permittees and persons conducting commercial cannabis activities at the site who do not maintain permits or licenses in good standing with the city, county or state may be grounds to commence an action to suspend or revoke the minor use permit pursuant to Chapter 17.80 SMC, or to revoke the required cannabis development/operating agreement. (Ord. 1047 § 2, 2018; Ord. 1043, 2017)